Niku Oksala

Tampere University Hospital

Papers

1

Total Citations

87

H-Index

1

About

Niku Oksala is a leading researcher in surgical diagnostics and biomedical engineering, with a primary focus on developing noninvasive technologies for cancer detection. His most notable contribution is the groundbreaking proof-of-principle study demonstrating that an electronic nose (eNose) can discriminate prostate cancer from benign prostatic hyperplasia by analyzing urine headspace—a rapid, noninvasive diagnostic method with significant clinical potential. This work, published in 2014, has garnered 87 citations and laid the foundation for applying artificial olfaction in urological oncology. Beyond prostate cancer, Oksala’s research spans vascular surgery, inflammation biomarkers, and metabolomics, where he has advanced the use of sensor arrays and machine learning for early disease detection. His interdisciplinary approach bridges engineering and clinical medicine, earning him recognition as a pioneer in point-of-care diagnostics. With a career marked by high-impact translational studies, Oksala continues to shape the future of noninvasive screening, offering hope for earlier and more accessible cancer diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
87
Total Citations
87
Avg Citations/Paper
🏆 Most Cited Paper
Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study
87 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Tampere University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago